PG
ARCC icon

Prostatis Group’s Ares Capital ARCC Stock Holding History

Prostatis Group’s Portfolio ARCC Stock Details ARCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Buy
19,898
+626
+3% +$11.7K 0.09% 126
2026
Q1 		$347K Buy
19,272
+495
+3% +$9.58K 0.09% 125
2025
Q4 		$380K Sell
18,777
-1,966
-9% -$39.7K 0.09% 117
2025
Q3 		$423K Sell
20,743
-1,493
-7% -$33.2K 0.11% 105
2025
Q2 		$488K Buy
22,236
+468
+2% +$9.95K 0.14% 97
2025
Q1 		$482K Buy
21,768
+457
+2% +$10.4K 0.15% 95
2024
Q4 		$467K Buy
21,311
+448
+2% +$9.66K 0.14% 107
2024
Q3 		$437K Buy
20,863
+461
+2% +$9.57K 0.14% 98
2024
Q2 		$425K Buy
20,402
+452
+2% +$9.44K 0.15% 102
2024
Q1 		$415K Hold
19,950
– – 0.16% 101
2023
Q4 		$400K Hold
19,950
– – 0.17% 95
2023
Q3 		$388K Hold
19,950
– – 0.19% 73
2023
Q2 		$375K Sell
19,950
-321
-2% -$5.93K 0.17% 80
2023
Q1 		$371K Buy
+20,271
New +$383K 0.2% 76

Other funds holding ARCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GAM
Generali Asset Management Trieste, Italy $5.53B AUM 35.1% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Prostatis Group's ARCC Position: Q2 2026 in Review

Prostatis Group increased its Ares Capital (ARCC) stake by 3.2% in Q2 2026, buying an estimated $11.7K and bringing the position to 19,898 shares worth $369K. The position accounts for 0.09% of the portfolio, ranked #126.

Prostatis Group first reported a position in ARCC in Q1 2023 and has held it in 14 quarters since. The position peaked at $488K in Q2 2025. 785 funds tracked by Wall St. Rank hold ARCC as of Q2 2026.

  • Prostatis Group held 19,898 shares of Ares Capital worth $369K as of Q2 2026.
  • Prostatis Group bought 626 Ares Capital shares in Q2 2026, an estimated $11.7K.
  • Ares Capital made up 0.09% of Prostatis Group's portfolio in Q2 2026, its #126 holding.
  • Prostatis Group first reported a position in Ares Capital in Q1 2023 and has held it in 14 quarters since.
  • Prostatis Group's Ares Capital position peaked at $488K in Q2 2025.
  • 785 funds tracked by Wall St. Rank held Ares Capital as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.